Literature DB >> 25243064

Chromium Picolinate for the Prevention of Type 2 Diabetes.

Ather Ali1, Yingying Ma2, Jesse Reynolds3, John Pierce Wise4, Silvio E Inzucchi5, David L Katz6.   

Abstract

Entities:  

Year:  2011        PMID： 25243064      PMCID： PMC4169208     

Source DB:  PubMed          Journal:  Treat Strategies Diabetes        ISSN： 2046-5793


× No keyword cloud information.
  25 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

2.  Chromium supplementation does not improve glucose tolerance, insulin sensitivity, or lipid profile: a randomized, placebo-controlled, double-blind trial of supplementation in subjects with impaired glucose tolerance.

Authors:  Jenny E Gunton; N Wah Cheung; Rosemary Hitchman; Graham Hams; Christine O'Sullivan; Kaye Foster-Powell; Aidan McElduff
Journal:  Diabetes Care       Date:  2005-03       Impact factor: 19.112

Review 3.  A systematic review of drug therapy to delay or prevent type 2 diabetes.

Authors:  Raj Padwal; Sumit R Majumdar; Jeff A Johnson; Janice Varney; Finlay A McAlister
Journal:  Diabetes Care       Date:  2005-03       Impact factor: 19.112

4.  Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes.

Authors:  Julie Martin; Zhong Q Wang; Xian H Zhang; Deborah Wachtel; Julia Volaufova; Dwight E Matthews; William T Cefalu
Journal:  Diabetes Care       Date:  2006-08       Impact factor: 19.112

5.  Adherence to preventive medications: predictors and outcomes in the Diabetes Prevention Program.

Authors:  Elizabeth A Walker; Mark Molitch; M Kaye Kramer; Steven Kahn; Yong Ma; Sharon Edelstein; Kellie Smith; Mariana Kiefer Johnson; Abbas Kitabchi; Jill Crandall
Journal:  Diabetes Care       Date:  2006-09       Impact factor: 19.112

6.  Pathophysiology and aetiology of impaired fasting glycaemia and impaired glucose tolerance: does it matter for prevention and treatment of type 2 diabetes?

Authors:  K Faerch; K Borch-Johnsen; J J Holst; A Vaag
Journal:  Diabetologia       Date:  2009-07-10       Impact factor: 10.122

7.  Phenotype of subjects with type 2 diabetes mellitus may determine clinical response to chromium supplementation.

Authors:  Zhong Q Wang; Jianhua Qin; Julie Martin; Xian H Zhang; Olga Sereda; Richard A Anderson; Patricia Pinsonat; William T Cefalu
Journal:  Metabolism       Date:  2007-12       Impact factor: 8.694

8.  Acute dark chocolate and cocoa ingestion and endothelial function: a randomized controlled crossover trial.

Authors:  Zubaida Faridi; Valentine Yanchou Njike; Suparna Dutta; Ather Ali; David L Katz
Journal:  Am J Clin Nutr       Date:  2008-07       Impact factor: 7.045

9.  Chromium supplementation of human subjects: effects on glucose, insulin, and lipid variables.

Authors:  R A Anderson; M M Polansky; N A Bryden; E E Roginski; W Mertz; W Glinsmann
Journal:  Metabolism       Date:  1983-09       Impact factor: 8.694

10.  Effects of walnut consumption on endothelial function in type 2 diabetic subjects: a randomized controlled crossover trial.

Authors:  Yingying Ma; Valentine Yanchou Njike; John Millet; Suparna Dutta; Kim Doughty; Judith A Treu; David L Katz
Journal:  Diabetes Care       Date:  2009-10-30       Impact factor: 19.112
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.